RWM
NUVB icon

Revisor Wealth Management’s Nuvation Bio NUVB Stock Holding History

Revisor Wealth Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Hold
18,520
– – 0.03% 364
2026
Q1 		$79.5K Buy
18,520
+5,317
+40% +$29.6K 0.02% 321
2025
Q4 		$90.1K Buy
+13,203
New +$81.8K 0.02% 319

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Revisor Wealth Management's NUVB Position: Q2 2026 in Review

Revisor Wealth Management held its Nuvation Bio (NUVB) position steady in Q2 2026 at 18,520 shares worth $105K. The position accounts for 0.03% of the portfolio, ranked #364.

Revisor Wealth Management first reported a position in NUVB in Q4 2025 and has held it in 3 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Revisor Wealth Management held 18,520 shares of Nuvation Bio worth $105K as of Q2 2026.
  • Revisor Wealth Management left its Nuvation Bio share count unchanged in Q2 2026.
  • Nuvation Bio made up 0.03% of Revisor Wealth Management's portfolio in Q2 2026, its #364 holding.
  • Revisor Wealth Management first reported a position in Nuvation Bio in Q4 2025 and has held it in 3 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Revisor Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.